
1.43 Delayed Data As of Mar 31 | ![]() Today’s Change | 1.17 Today|||52-Week Range 7.09 | -39.41% Year-to-Date |
The 4 analysts offering 12-month price forecasts for Sellas Life Sciences Group Inc have a median target of 6.00, with a high estimate of 9.00 and a low estimate of 3.00. The median estimate represents a +319.58% increase from the last price of 1.43.
The current consensus among 4 polled investment analysts is to Buy stock in Sellas Life Sciences Group Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.